Literature DB >> 23089913

A case of intraperitoneal immunoglobulin G4-related inflammatory pseudotumor.

In Ho Moh1, Jin Bae Kim, Su Rin Shin, Sung Won Jung, Sang Hoon Park, Jeong Won Kim, Mi Kyung Shin, Myung Seok Lee.   

Abstract

The term inflammatory pseudotumor (IPT) has been used to describe inflammatory and fibrosing tumoral processes of an undetermined cause that may involve a variety of organ system. IgG4-related disease is a newly recognized fibroinflammatory condition characterized by IgG4-producing plasma cell expansion in affected organs and, often but not always, elevated serum IgG4 concentrations. IgG4-related IPTs, a subtype of IPT, are characterized by dense infiltration of IgG4-positive plasma cells and stromal fibrosis. The association between inflammatory pseudotumor and IgG4 was first reported with a regard to sclerosing pancreatitis. Despite there are many reports on intraperitoneal IPTs including both cellular and lymphoplasmacytic type, only a few cases have been confirmed to be IgG4-related. We experienced a case of intraperitoneal IgG4-related inflammatory pseudotumor in an 83-year-old woman presenting with epigastric pain and malaise. Surgical specimens revealed an IgG4-related inflammatory pseudotumor.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23089913     DOI: 10.4166/kjg.2012.60.4.258

Source DB:  PubMed          Journal:  Korean J Gastroenterol        ISSN: 1598-9992


  2 in total

1.  An immunoglobulin G4-related sclerosing disease of the small bowel: CT and small bowel series findings.

Authors:  Younghwan Ko; Ji Young Woo; Jeong Won Kim; Hye Sook Hong; Ik Yang; Yul Lee; Daehyun Hwang; Seon Jeong Min
Journal:  Korean J Radiol       Date:  2013-08-30       Impact factor: 3.500

2.  Small bowel obstruction caused by peritoneal immunoglobulin g4-related disease mimicking carcinomatosis: case report.

Authors:  Bruno Coulier; Luc Montfort; Gabriela Beniuga; Frederic Pierard; Isabelle Gielen
Journal:  Korean J Radiol       Date:  2014-01-08       Impact factor: 3.500

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.